Notably, the activated AKT promotes NRF2 translocation to the nucleus and then the transactivation of the downstream target genes, inhibiting oxidative stress in HFD‐induced obesity (Li et al. 2020; Liu et al. 2016). The gene discussed is NFE2L2; the disease is Obesity.